Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience

Eren O. O., Artac M., Boruban M. C., Yavas O., Arslan U., Basaranoglu M.

MEDICAL ONCOLOGY, cilt.26, sa.4, ss.386-392, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 4
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s12032-008-9133-4
  • Dergi Adı: MEDICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.386-392
  • Anahtar Kelimeler: Hepatitis B, Cytotoxic chemotherapy, Reactivation, Cancer, Lamivudine, CYTOTOXIC CHEMOTHERAPY, HBV REACTIVATION, PREEMPTIVE USE, RISK-FACTORS, LAMIVUDINE, CARRIERS, THERAPY, MALIGNANCIES, PREVENTION, INFECTION
  • Bezmiâlem Vakıf Üniversitesi Adresli: Hayır

Özet

Hepatitis B reactivation due to chemotherapy is a cause of serious morbidity and mortality in some of the patients with cancer. In this study, we retrospectively assessed the prevalence of hepatitis B reactivation among the patients undergoing cytotoxic chemotherapy. We investigated efficacy of lamivudine prophylaxis against hepatitis B reactivation as well.